1. Home
  2. IMTE vs PRFX Comparison

IMTE vs PRFX Comparison

Compare IMTE & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integrated Media Technology Limited

IMTE

Integrated Media Technology Limited

HOLD

Current Price

$0.65

Market Cap

2.4M

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$3.06

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMTE
PRFX
Founded
2008
2007
Country
Australia
Israel
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
IMTE
PRFX
Price
$0.65
$3.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.1M
1.3M
Earning Date
10-22-2024
10-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$72,641.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$2.57
52 Week High
$3.17
$27.35

Technical Indicators

Market Signals
Indicator
IMTE
PRFX
Relative Strength Index (RSI) 41.68 76.82
Support Level $0.58 $2.57
Resistance Level $0.67 $3.71
Average True Range (ATR) 0.09 0.28
MACD -0.02 0.24
Stochastic Oscillator 6.32 72.51

Price Performance

Historical Comparison
IMTE
PRFX

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is mainly engaged in the business of manufacture and sale of nano-coated plates for filters, the manufacture and sale of electronic glass, Halal certification and distribution of Halal products, and new energy products and services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: